查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2170449

輸尿管鏡市場機會、成長要素、產業趨勢分析及2026-2035年預測

Ureteroscope Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，輸尿管鏡市場規模將超過 15.6 億美元，年複合成長率為 8.3%，到 2035 年將達到 34.5 億美元。

市場範圍
開始年份 2025
預測期 2026-2035
上市時的市場規模 15.6億美元
預計金額 34.5億美元
複合年成長率 8.3%

儘管泌尿系統結石的負擔持續推動著對內視鏡泌尿系統手術的需求，但診斷可近性的提高也使得以往漏診的病例得以納入治療流程。這意味著設備採購如今與持續的臨床需求掛鉤，而非僅圍繞單一的設備週期。門診手術的增加正在改變設備所有權模式和工作流程。優先考慮可預測排班和高效支援的醫療機構可以透過使用一次性內視鏡來避免維持內部的再處理流程。此外，數位化一次性產品透過提升影像品質、增強主動彎曲功能和整合式視覺化技術，正在縮小與高階可重複使用系統之間的效能差距。這使得客戶能夠在更廣泛的手術範圍內評估一次性產品，而無需擔心維修風險或週轉時間。隨著這些進步拓寬了採購選擇，臨床表現和操作適用性正成為醫院和門診各級決策的核心。

從產品類型來看，預計到2025年，軟性輸尿管鏡的全球整體銷售額將達到10.6億美元。其操作靈活性和與雷射碎石術的兼容性，使其能夠支持需要進入腎盂輸尿管系統的手術。數位成像技術增強了可視性，有助於滿足複雜結石處理的需求。可重複使用和一次性產品在這些應用中競爭，提供不同的所有權和支援結構。供應商必須根據醫療機構的工作流程和計劃的手術調整產品性能。因此，該細分市場的商業性意義在於滿足臨床對進入和可視性的需求，以及在設備管理方面的實際選擇。能夠提供合適的成像和操作特性的製造商，可以滿足客戶評估所選平台的手術能力和營運影響的需求。

從易用性角度來看，可重複使用輸尿管鏡市場預計到2035年將達到16.2億美元。醫院的資本投資預算、完善的消毒部門以及高手術量都支撐著持續的採購需求。在擁有成熟的再處理系統的醫療機構中，週轉和維修風險可以在現有系統內有效管理。即使一次性產品的選擇不斷增加，高品質的可重複使用數位設備仍然保持其實用性。服務於該領域的供應商必須提供可靠的設備和服務，以適應此類工作流程。因此，該類別的市場定位反映的是操作上的適用性，而不是對特定技術型號的統一偏好。客戶會綜合評估設備的耐用性、可用處理能力和手術需求，因此設備性能與醫療機構現有基礎設施之間的關係在採購決策中至關重要。

預計到2025年，北美輸尿管鏡市場規模將達5.93億美元。大量的手術、先進的泌尿內泌尿系統服務以及完善的門診手術網路，都為數位化產品和一次性產品提供了支援。過去的健保報銷機制也促進了一次性泌尿內視鏡的發展。供應商在一個成熟的採購環境中競爭，除了臨床能力之外，服務應對力和合約簽訂也至關重要。客戶需要適合其醫療機構手術環境和營運資源的平台。因此，北美市場憑藉其成熟醫院的需求和門診應用的普及，為可重複使用產品和一次性產品都提供了獨特的商機。能夠同時滿足性能要求和實際採購條件的製造商，可以滿足醫療機構的需求，幫助他們選擇能夠反映其體外碎石術整個工作流程的器械。

到了2025年，波士頓科學公司佔25%的市場。 LithoVue鞏固了其在一次性軟性輸尿管鏡市場的地位，而StoneSmart Solutions則將可視化功能與取石、清潔和配件整合在一起。這種全面的解決方案滿足了那些不僅關注內視鏡本身，更關注整個手術流程的客戶的需求。醫院和門診機構需要能夠與其服務模式協同運作的產品，而這種整合具有商業性價值。因此，波士頓科學的市場地位既體現了其醫療設備業務，也體現了其更廣泛的結石管理產品組合。多種功能的整合加強了與尋求穩定獲取手術器械的客戶的關係，而一次性產品的提供則滿足了那些考慮確保無菌和可重複使用設備相關操作要求的客戶的需求。

該市場的主要參與者包括Olympus Corporation、卡爾史托斯公司、Amb A/S、OPCOM Medical、科樂普、多尼爾醫療科技和理查德沃爾夫。Olympus透過可重複使用產品與客戶建立聯繫，並持續拓展產品系列。卡爾史托斯強調耐用器械及其在醫院內的整合應用，而Amb則專注於在資源有限的環境中提供無菌一次性產品。 OPCOM致力於滿足那些希望以具有競爭力的價格獲得一次性產品優勢的客戶的需求。其他公司則透過廣泛的泌尿系統產品線或在內視鏡研發方面的專案投入進入市場。競爭格局日益擴大，涵蓋了影像、服務經濟性、器械尺寸和整合手術等多個面向。供應商需要將這些特性與臨床醫生的偏好和採購要求相結合，無論是在醫院還是門診，可靠的支援和對各種器械型號的兼容性都至關重要。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 行業洞察

  • 產業生態系分析
  • 影響產業的因素
    • 促進因素
      • 腎結石和泌尿系統疾病發生率增加
      • 輸尿管鏡檢查的技術進步
      • 微創醫療設備的廣泛應用
    • 產業潛在風險與挑戰
      • 先進的數位輸尿管鏡高成本
    • 機會
      • 進入新興市場
      • 輸尿管鏡和機器人手術系統的整合
  • 成長潛力分析
  • 監理情勢
    • 北美洲
    • 歐洲
  • 技術與創新展望
    • 最新科技趨勢
    • 新興技術
  • 價格趨勢：依產品分類
  • 未來市場趨勢
  • 救贖方案
  • 消費行為分析
  • 差距分析
  • 波特的分析
  • PESTLE分析

第4章 競爭情勢

  • 介紹
  • 企業市佔率分析
    • 世界
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 企業矩陣分析
  • 主要市場公司的競爭分析
  • 競爭定位矩陣
  • 主要進展
    • 併購
    • 夥伴關係和聯盟
    • 新產品發布
    • 業務拓展計劃

第5章 市場估算與預測：依產品分類，2026-2035年

  • 主要趨勢
  • 軟式輸尿管鏡
  • 硬式輸尿管鏡

第6章 市場估算與預測：依可用性分類，2026-2035年

  • 主要趨勢
  • 可重複使用的輸尿管鏡
  • 拋棄式輸尿管鏡

第7章 市場估計與預測：依應用領域分類，2026-2035年

  • 主要趨勢
  • 尿道結石
  • 尿道狹窄
  • 尿道感染
  • 其他用途

第8章 市場估算與預測：依最終用途分類，2026-2035年

  • 主要趨勢
  • 醫院
  • 門診手術中心
  • 其他最終用途

第9章 市場估計與預測：依地區分類，2026-2035年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE

第10章：公司簡介

  • Ambu
  • BD
  • Boston Scientific
  • Coloplast
  • Dornier MedTech
  • Neoscope
  • Olympus
  • OPCOM Medical
  • PUSEN
  • Richard Wolf
  • KARL STORZ
  • Stryker
簡介目錄
Product Code: 14356

The Ureteroscope Market exceeded USD 1.56 billion in 2025 and is projected to grow at 8.3% CAGR to reach USD 3.45 billion by 2035.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$1.56 Billion
Forecast Value$3.45 Billion
CAGR8.3%

The burden of stone disease supports continuing demand for endourology procedures, while better diagnostic access brings previously underdetected cases into treatment pathways. This connects procurement with a recurring clinical need rather than a single equipment cycle. Growth in ambulatory surgery changes the preferred ownership and workflow model. Facilities focused on predictable scheduling and lean support can use disposable scopes to avoid maintaining local reprocessing operations. Digital single-use products also narrow the performance gap with premium reusable systems through improved imaging, active deflection, and integrated visualization. Customers can therefore evaluate disposables in a wider set of procedures without accepting the same repair exposure or turnaround requirements. These developments broaden procurement choices while making clinical performance and operational suitability central to decisions across hospital and outpatient settings.

Based on product type, flexible ureteroscopes generated USD 1.06 billion in global revenue in 2025. Maneuverability and compatibility with laser lithotripsy support procedures requiring access within the kidney's collecting system. Digital imaging improves visualization and helps address complex stone-management requirements. Reusable and single-use products compete within these applications while offering different ownership and support arrangements. Suppliers need to align performance with the provider's workflow and intended procedures. The segment's commercial relevance therefore combines a clinical requirement for access and visualization with practical choices about device management. Manufacturers able to provide suitable imaging and handling characteristics can address customers assessing both procedural capability and the operating implications of the platform they select.

By usability, reusable ureteroscopes are projected to reach USD 1.62 billion by 2035. Hospital capital budgets, established sterile-processing departments, and high procedural volumes support continued purchasing. Facilities with mature reprocessing operations can manage turnaround and repair exposure within their existing systems. This preserves a practical role for premium reusable digital devices even as disposable options expand. Suppliers serving the segment need dependable instruments and service suited to those workflows. The category's commercial position therefore reflects operational fit rather than a uniform preference for one technology model. Customers evaluate durability, available processing capability, and procedure needs together, making the relationship between device performance and the provider's existing infrastructure important to procurement decisions.

The North America ureteroscope market generated USD 593 million in 2025. Substantial procedure volumes, advanced endourology services, and established ambulatory surgery networks support digital and single-use products. Historical reimbursement arrangements also contributed to the development of disposable urinary tract endoscopy. Suppliers compete within a mature procurement environment where service responsiveness and contract access matter alongside clinical capabilities. Customers need platforms suitable for their procedure setting and operational resources. The regional market therefore combines established hospital demand with outpatient adoption, creating different opportunities for reusable and disposable offerings. Manufacturers able to support both performance requirements and practical purchasing arrangements can address providers whose device choices increasingly reflect the complete workflow of stone-management services.

Boston Scientific Corporation accounted for 25% of market share in 2025. LithoVue supports its position in single-use flexible ureteroscopy, while StoneSmart Solutions connects visualization with lithotripsy, irrigation, and accessories. This broader approach addresses customers evaluating the complete procedural workflow rather than a scope alone. Hospitals and ambulatory facilities need products that work together within their service model, making integration commercially useful. Boston Scientific's position therefore reflects both the device franchise and a wider stone-management portfolio. Connecting several functions can strengthen account relationships where buyers seek consistent access to procedural tools, while the single-use offering addresses customers evaluating sterile availability and the operating demands associated with reusable equipment.

Some of the major players in this market are Olympus Corporation, Karl Storz SE and Co. KG, Ambu A/S, OPCOM Medical, Coloplast, Dornier MedTech, and Richard Wolf. Olympus combines reusable relationships with a growing disposable portfolio. Karl Storz emphasizes durable instruments and hospital integration, while Ambu focuses on sterile single-use availability in leaner settings. OPCOM addresses customers seeking disposable benefits at competitive acquisition prices. Other companies participate through wider urology ranges and focused endoscopy development. Competition increasingly involves imaging, service economics, device dimensions, and integrated procedures. Suppliers must connect those features with clinician preferences and procurement requirements, making dependable support and the ability to serve different device models important across hospitals and outpatient facilities.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1 Market Scope and Definitions
  • 1.2 Research Design
    • 1.2.1 Research Approach
    • 1.2.2 Data Collection Methods
  • 1.3 Data Mining Sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base Estimates and Calculations
    • 1.4.1 Base Year Calculation
    • 1.4.2 Key Trends for Market Estimation
  • 1.5 Primary Research and Validation
    • 1.5.1 Primary Sources
  • 1.6 Forecast Model
  • 1.7 Research Assumptions and Limitations

Chapter 2. Executive Summary

  • 2.1 Industry 360° Synopsis
  • 2.2 Key Market Trends
    • 2.2.1 Regional
    • 2.2.2 Product
    • 2.2.3 Usability
    • 2.2.4 Application
    • 2.2.5 End Use
  • 2.3 CXO Perspectives: Strategic Imperatives
    • 2.3.1 Key Decision Points for Industry Executives
    • 2.3.2 Critical Success Factors for Market Players
  • 2.4 Future Outlook and Strategic Recommendations

Chapter 3. Industry Insights

  • 3.1 Industry Ecosystem Analysis
  • 3.2 Industry Impact Forces
    • 3.2.1 Growth Drivers
      • 3.2.1.1 Increasing Prevalence of Kidney Stones and Urinary Tract Diseases
      • 3.2.1.2 Technological Advancements in Ureteroscopy
      • 3.2.1.3 Growing Adoption of Minimally Invasive Devices
    • 3.2.2 Industry Pitfalls and Challenges
      • 3.2.2.1 High Cost of Advanced and Digital Ureteroscopes
    • 3.2.3 Opportunities
      • 3.2.3.1 Expansion into Emerging Markets
      • 3.2.3.2 Integration of Ureteroscopes with Robotic Surgical Systems
  • 3.3 Growth Potential Analysis
  • 3.4 Regulatory Landscape
    • 3.4.1 North America
    • 3.4.2 Europe
  • 3.5 Technology and Innovation Landscape
    • 3.5.1 Current Technological Trends
    • 3.5.2 Emerging Technologies
  • 3.6 Price Trends, by Product
  • 3.7 Future Market Trends
  • 3.8 Reimbursement Scenario
  • 3.9 Consumer Behaviour Analysis
  • 3.10 Gap Analysis
  • 3.11 Porter's Analysis
  • 3.12 PESTEL Analysis

Chapter 4. Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company Market Share Analysis
    • 4.2.1 Global
    • 4.2.2 North America
    • 4.2.3 Europe
    • 4.2.4 Asia Pacific
    • 4.2.5 Latin America
    • 4.2.6 MEA
  • 4.3 Company Matrix Analysis
  • 4.4 Competitive Analysis of Major Market Players
  • 4.5 Competitive Positioning Matrix
  • 4.6 Key Developments
    • 4.6.1 Mergers and Acquisitions
    • 4.6.2 Partnerships and Collaborations
    • 4.6.3 New Product Launches
    • 4.6.4 Expansion Plans

Chapter 5. Market Estimates and Forecast, By Product, 2026-2035 ($ Mn)

  • 5.1 Key Trends
  • 5.2 Flexible Ureteroscope
  • 5.3 Rigid Ureteroscope

Chapter 6. Market Estimates and Forecast, By Usability, 2026-2035 ($ Mn)

  • 6.1 Key Trends
  • 6.2 Reusable Ureteroscopes
  • 6.3 Disposable Ureteroscopes

Chapter 7. Market Estimates and Forecast, By Application, 2026-2035 ($ Mn)

  • 7.1 Key Trends
  • 7.2 Urolithiasis
  • 7.3 Urethral Stricture
  • 7.4 Urinary Tract Infections
  • 7.5 Other Applications

Chapter 8. Market Estimates and Forecast, By End Use, 2026-2035 ($ Mn)

  • 8.1 Key Trends
  • 8.2 Hospitals
  • 8.3 Ambulatory Surgical Centers
  • 8.4 Other End Use

Chapter 9. Market Estimates and Forecast, By Region, 2026-2035 ($ Mn)

  • 9.1 Key Trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10. Company Profiles

  • 10.1 Ambu
  • 10.2 BD
  • 10.3 Boston Scientific
  • 10.4 Coloplast
  • 10.5 Dornier MedTech
  • 10.6 Neoscope
  • 10.7 Olympus
  • 10.8 OPCOM Medical
  • 10.9 PUSEN
  • 10.10 Richard Wolf
  • 10.11 KARL STORZ
  • 10.12 Stryker